Acomo N.v. · EURONEXT:ACOMO
Acomo — Investor Day (April 2025)
18 slides from Acomo's investor day presentation, Apr 7, 2025
Slide 1: Value creation & financial objectives
5 speakers 5 Value creation & financial objectives Mirjam van Thiel | ACOMO N.V. - CMD 7 April 2025
Slide 2: Acomo – Mirjam van Thiel
Acomo – Mirjam van Thiel Rotterdam (NL), April 7, 2025
Slide 3: Acomo is well positioned for long-term value creation
Acomo is well positioned for long-term value creation Value creation tree | ACOMO N.V. - CMD 7 April 2025
Slide 4: Strategic financial objectives
Strategic financial objectives Mid-term value creation objectives Further building scale in specialty markets Sales € 2 Billion Maintain a strong balance sheet; Delivering a Remain an attractive remain resilient to market healthy margin dividend payer changes and manage risks EBITDA Debt / EBITDA Di
Slide 5: Proven track record
Further building scale Healthy EBITDA margin Strong balance sheet Attractive dividend Proven track record Sales Adjusted EBITDA Euro million Euro million 1,423 1,363 108 109 101 1,254 1,266 92 Growth opportunities: 707 52 • Organic • M&A 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 Total Total
Slide 6: Growth path towards €2B of Sales
Further building scale Healthy EBITDA margin Strong balance sheet Attractive dividend Growth path towards €2B of Sales Sales Bolt-on and Euro Billion selective transformational 5% p.a. organic M&A 2.0 growth 1.4 2024 Organic growth M&A 5 year target | ACOMO N.V. - CMD 7 April 2025
Slide 7: Organic growth | further build scale in specialty markets
Further building scale Healthy EBITDA margin Strong balance sheet Attractive dividend Organic growth | further build scale in specialty markets Geographic expansion White space New markets Grow existing businesses Portfolio extension Existing markets Size represents share of growth Included in the b
Slide 8: M&A focus areas
Further building scale Healthy EBITDA margin Strong balance sheet Attractive dividend M&A focus areas Europe Americas Spices and Nuts Priority (bolt on or transformational) Edible Seeds Priority (bolt on or transformational) Organic Ingredients Priority (bolt on) Tea Continue to maximize potential o
Slide 9: M&A Criteria
Further building scale Healthy EBITDA margin Strong balance sheet Attractive dividend M&A Criteria Strategic Fit Financial Fit Cultural Fit Active within plant-based Finance synergies, and bolt-on Aligned with Acomo’s core values: ingredients within specialty markets revenue and cost synergies entre
Slide 10: EBITDA% demonstrating the value added role of Acomo
Further building scale Healthy EBITDA margin Strong balance sheet Attractive dividend EBITDA% demonstrating the value added role of Acomo Peer comparison 18.1% EBITDA % of Sales 13.6% 14.0% 12.8% 8.0% 6.5% 4.8% 5.2% 3.2% The Olam ADM Bunge AAK Corbion Glanbia Kerry Andersons Traders F&B ingredients
Slide 11: Opportunity within the portfolio to improve margin
Further building scale Healthy EBITDA margin Strong balance sheet Attractive dividend Opportunity within the portfolio to improve margin EBITDA % of Sales 24% Average last 3 year adjusted EBITDA1 10% 11% 8% 5% 6% Tea Organic Ingredients Edible Seeds Spices & Nuts Food Solutions Improve through Grow
Slide 12: Capital Allocation Strategy
Capital Allocation Strategy Manage volatility Strong balance sheet Maintain room to take strategic positions Invest in profitable growth Invest in capabilities and capacity Invest in building scale Bolt on and transformational acquisitions Dividend Attractive dividend ratio | ACOMO N.V. - CMD 7 Apri
Slide 13: Maintain a strong Balance Sheet
Further building scale Healthy EBITDA margin Strong balance sheet Attractive dividend Maintain a strong Balance Sheet • Healthy solvency ratio’s Strong 54.5% solvency ratio 48.1% 50.7% 42.2% • Leverage ratio quickly Equity / assets 41.1% returned to normalised levels post acquisition of Tradin in 20
Slide 14: Maintain a strong balance sheet
Further building scale Healthy EBITDA margin Strong balance sheet Attractive dividend Maintain a strong balance sheet • Working capital as a Financial 472 480 420 420 452 420 387 commercial instrument headroom 275 EUR million • Financial headroom to Trade working Capital manage volatility Utilised H
Slide 15: Remain an attractive dividend payer
Further building scale Healthy EBITDA margin Strong balance sheet Attractive dividend Remain an attractive dividend payer 3.0 100 83% 85% 86% 80% 79% 82% 2.5 74% 80 68% 2.0 60 1.5 37% 40 33% 1.0 20 0.5 0.0 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 * Adjusted earnings / share Dividend / share
Slide 16: Proven track record
Proven track record Sales € B 2.0 Sales growth 8% per annum 1.4 Grow to (organically +4%) 2B Sales 0.7 in 5 years ’15 ’16 ’17 ’18 ’19 ’20 ’21 ’22 ’23 ’24 ’29 Adjusted EBITDA% With steady ...while improving EBITDA EBITDA at 8% … 8% 8% c. 9% to c. 9%, by focusing on added value and portfolio managemen
Slide 17: Proven track record to further accelerate growth
Proven track record to further accelerate growth Sales € B 2.0 Sales growth 8% per annum 1.4 Grow to (organically +4%) 0.7 €2B Sales in 5 years ’15 ’16 ’17 ’18 ’19 ’20 ’21 ’22 ’23 ’24 ’29 Adjusted EBITDA% With steady ...while improving EBITDA EBITDA at 8% … 8% 8% c. 9% to c. 9%, by focusing on addin
Slide 18: Key takeaways
Key takeaways Strong base Growth opportunities, both organic as well as via acquisitions Financial headroom Long term shareholder value | ACOMO N.V. - CMD 7 April 2025